Concepts (215)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome-Wide Association Study | 21 | 2022 | 271 | 1.890 |
Why?
|
| Polymorphism, Single Nucleotide | 21 | 2022 | 638 | 1.160 |
Why?
|
| Quantitative Trait Loci | 4 | 2022 | 68 | 1.130 |
Why?
|
| Obesity | 13 | 2021 | 965 | 0.750 |
Why?
|
| Models, Statistical | 1 | 2021 | 171 | 0.720 |
Why?
|
| Genetic Loci | 7 | 2018 | 70 | 0.710 |
Why?
|
| Heart Diseases | 2 | 2018 | 99 | 0.690 |
Why?
|
| Body Mass Index | 13 | 2018 | 775 | 0.690 |
Why?
|
| Apolipoproteins E | 1 | 2018 | 129 | 0.610 |
Why?
|
| Heart Rate | 1 | 2018 | 248 | 0.580 |
Why?
|
| Genetic Predisposition to Disease | 13 | 2018 | 528 | 0.570 |
Why?
|
| Blood Glucose | 6 | 2019 | 333 | 0.550 |
Why?
|
| Cognition | 2 | 2018 | 373 | 0.540 |
Why?
|
| Blood Pressure | 2 | 2023 | 613 | 0.540 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 881 | 0.530 |
Why?
|
| Hippocampus | 1 | 2018 | 546 | 0.500 |
Why?
|
| Genotype | 9 | 2018 | 641 | 0.420 |
Why?
|
| Insulin | 4 | 2015 | 224 | 0.400 |
Why?
|
| Humans | 42 | 2023 | 34853 | 0.390 |
Why?
|
| Exercise | 4 | 2022 | 524 | 0.370 |
Why?
|
| Survival Analysis | 3 | 2021 | 322 | 0.360 |
Why?
|
| Dietary Proteins | 3 | 2014 | 30 | 0.360 |
Why?
|
| Phenotype | 7 | 2022 | 650 | 0.350 |
Why?
|
| Body Composition | 2 | 2019 | 146 | 0.330 |
Why?
|
| Aged | 17 | 2022 | 6448 | 0.330 |
Why?
|
| Male | 26 | 2021 | 18870 | 0.320 |
Why?
|
| Cardiovascular Diseases | 4 | 2023 | 628 | 0.310 |
Why?
|
| Female | 26 | 2021 | 19873 | 0.310 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 841 | 0.280 |
Why?
|
| Dietary Fats | 4 | 2014 | 115 | 0.270 |
Why?
|
| Heart Failure | 3 | 2018 | 230 | 0.270 |
Why?
|
| Middle Aged | 20 | 2022 | 9642 | 0.270 |
Why?
|
| Dietary Carbohydrates | 3 | 2014 | 30 | 0.260 |
Why?
|
| Transportation of Patients | 1 | 2022 | 14 | 0.220 |
Why?
|
| Brain-Derived Neurotrophic Factor | 3 | 2019 | 58 | 0.220 |
Why?
|
| Risk Factors | 8 | 2019 | 3414 | 0.220 |
Why?
|
| Triglycerides | 3 | 2019 | 129 | 0.210 |
Why?
|
| Energy Intake | 4 | 2018 | 160 | 0.210 |
Why?
|
| Patient Participation | 1 | 2022 | 68 | 0.210 |
Why?
|
| Insulin Resistance | 2 | 2015 | 177 | 0.210 |
Why?
|
| Body Height | 2 | 2013 | 52 | 0.210 |
Why?
|
| Receptors, Cell Surface | 1 | 2022 | 135 | 0.200 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 195 | 0.200 |
Why?
|
| Bariatric Surgery | 1 | 2021 | 14 | 0.200 |
Why?
|
| Gastric Bypass | 1 | 2021 | 14 | 0.200 |
Why?
|
| Proportional Hazards Models | 3 | 2018 | 423 | 0.200 |
Why?
|
| Aged, 80 and over | 5 | 2018 | 2333 | 0.200 |
Why?
|
| Bayes Theorem | 1 | 2021 | 91 | 0.190 |
Why?
|
| Overweight | 2 | 2019 | 233 | 0.180 |
Why?
|
| Weight Loss | 1 | 2021 | 124 | 0.180 |
Why?
|
| Intensive Care Units | 2 | 2017 | 57 | 0.180 |
Why?
|
| Fibroblast Growth Factors | 3 | 2018 | 34 | 0.180 |
Why?
|
| Lipoproteins, LDL | 1 | 2019 | 61 | 0.180 |
Why?
|
| Cohort Studies | 7 | 2018 | 1422 | 0.180 |
Why?
|
| Epistasis, Genetic | 2 | 2017 | 15 | 0.170 |
Why?
|
| Anorexia Nervosa | 1 | 2018 | 6 | 0.170 |
Why?
|
| Adiposity | 2 | 2017 | 145 | 0.170 |
Why?
|
| Computer Simulation | 1 | 2021 | 347 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 468 | 0.170 |
Why?
|
| Vital Capacity | 1 | 2018 | 38 | 0.170 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2019 | 281 | 0.170 |
Why?
|
| Forced Expiratory Volume | 1 | 2018 | 68 | 0.160 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2017 | 14 | 0.160 |
Why?
|
| Docosahexaenoic Acids | 1 | 2017 | 18 | 0.160 |
Why?
|
| Antihypertensive Agents | 1 | 2021 | 284 | 0.160 |
Why?
|
| Seafood | 1 | 2017 | 19 | 0.160 |
Why?
|
| Neuropsychological Tests | 1 | 2018 | 255 | 0.150 |
Why?
|
| Critical Illness | 1 | 2017 | 37 | 0.150 |
Why?
|
| Alleles | 5 | 2016 | 284 | 0.150 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2014 | 77 | 0.150 |
Why?
|
| Patient Selection | 1 | 2017 | 154 | 0.140 |
Why?
|
| Receptors, Cytokine | 1 | 2016 | 11 | 0.140 |
Why?
|
| Apolipoprotein E4 | 1 | 2016 | 47 | 0.140 |
Why?
|
| Mental Disorders | 1 | 2019 | 285 | 0.140 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 143 | 0.140 |
Why?
|
| Expiratory Reserve Volume | 1 | 2015 | 2 | 0.140 |
Why?
|
| Functional Residual Capacity | 1 | 2015 | 2 | 0.140 |
Why?
|
| Meat Products | 1 | 2015 | 6 | 0.140 |
Why?
|
| Hyperinsulinism | 1 | 2015 | 17 | 0.140 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 79 | 0.140 |
Why?
|
| Meat | 1 | 2015 | 41 | 0.130 |
Why?
|
| Insulin-Secreting Cells | 1 | 2015 | 27 | 0.130 |
Why?
|
| Adult | 11 | 2021 | 11034 | 0.130 |
Why?
|
| Sepsis | 1 | 2016 | 76 | 0.130 |
Why?
|
| Coffea | 1 | 2014 | 3 | 0.130 |
Why?
|
| Atrial Fibrillation | 1 | 2016 | 105 | 0.130 |
Why?
|
| Hyperglycemia | 1 | 2015 | 53 | 0.130 |
Why?
|
| Cholesterol, LDL | 1 | 2014 | 63 | 0.130 |
Why?
|
| Fasting | 2 | 2012 | 50 | 0.120 |
Why?
|
| Chromosome Mapping | 2 | 2012 | 159 | 0.120 |
Why?
|
| Logistic Models | 1 | 2016 | 894 | 0.120 |
Why?
|
| Hypertension | 1 | 2021 | 770 | 0.120 |
Why?
|
| Aging | 1 | 2018 | 639 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2017 | 371 | 0.120 |
Why?
|
| Lipoprotein Lipase | 1 | 2012 | 5 | 0.110 |
Why?
|
| Carbohydrate Metabolism | 1 | 2012 | 20 | 0.110 |
Why?
|
| Trace Elements | 1 | 2013 | 25 | 0.110 |
Why?
|
| Hematopoiesis | 1 | 2013 | 30 | 0.110 |
Why?
|
| DNA Methylation | 1 | 2016 | 301 | 0.110 |
Why?
|
| Dietary Fiber | 1 | 2013 | 42 | 0.110 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2013 | 43 | 0.110 |
Why?
|
| Anthropometry | 1 | 2013 | 91 | 0.110 |
Why?
|
| Lung | 1 | 2015 | 413 | 0.110 |
Why?
|
| Smoking | 2 | 2017 | 903 | 0.110 |
Why?
|
| Blood Proteins | 1 | 2012 | 65 | 0.110 |
Why?
|
| Magnesium | 1 | 2013 | 95 | 0.110 |
Why?
|
| Weight Gain | 1 | 2013 | 128 | 0.110 |
Why?
|
| Waist-Hip Ratio | 3 | 2017 | 32 | 0.110 |
Why?
|
| Models, Genetic | 1 | 2012 | 149 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 298 | 0.100 |
Why?
|
| Proteins | 1 | 2014 | 352 | 0.100 |
Why?
|
| Cation Transport Proteins | 1 | 2011 | 30 | 0.100 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2011 | 36 | 0.100 |
Why?
|
| Homeostasis | 1 | 2012 | 172 | 0.100 |
Why?
|
| Coronary Disease | 1 | 2012 | 113 | 0.100 |
Why?
|
| Lipids | 1 | 2012 | 222 | 0.100 |
Why?
|
| Bone Marrow Cells | 1 | 2011 | 75 | 0.100 |
Why?
|
| Feeding Behavior | 1 | 2014 | 418 | 0.100 |
Why?
|
| Zinc | 1 | 2011 | 114 | 0.090 |
Why?
|
| Stem Cells | 1 | 2011 | 132 | 0.090 |
Why?
|
| United States | 5 | 2018 | 3894 | 0.090 |
Why?
|
| Educational Status | 2 | 2022 | 295 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 2561 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2018 | 1056 | 0.080 |
Why?
|
| Body Weight | 1 | 2010 | 404 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2011 | 296 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2012 | 386 | 0.080 |
Why?
|
| Genomics | 2 | 2018 | 201 | 0.080 |
Why?
|
| Waist Circumference | 2 | 2017 | 82 | 0.070 |
Why?
|
| Diet | 1 | 2012 | 747 | 0.070 |
Why?
|
| Comorbidity | 2 | 2019 | 606 | 0.070 |
Why?
|
| Sex Factors | 2 | 2019 | 859 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2019 | 628 | 0.070 |
Why?
|
| Genetic Variation | 2 | 2019 | 328 | 0.070 |
Why?
|
| Hospital Mortality | 2 | 2017 | 183 | 0.070 |
Why?
|
| Age Factors | 2 | 2019 | 1007 | 0.060 |
Why?
|
| Prognosis | 2 | 2018 | 707 | 0.060 |
Why?
|
| Linkage Disequilibrium | 2 | 2012 | 58 | 0.060 |
Why?
|
| Amyloid | 1 | 2023 | 52 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 570 | 0.060 |
Why?
|
| Positron-Emission Tomography | 1 | 2023 | 79 | 0.050 |
Why?
|
| Linear Models | 2 | 2013 | 253 | 0.050 |
Why?
|
| Memory | 1 | 2022 | 165 | 0.050 |
Why?
|
| Multifactorial Inheritance | 1 | 2019 | 14 | 0.050 |
Why?
|
| Prevalence | 2 | 2016 | 1425 | 0.050 |
Why?
|
| Physical Fitness | 1 | 2019 | 78 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 968 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2013 | 1353 | 0.040 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2018 | 25 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2018 | 90 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2022 | 531 | 0.040 |
Why?
|
| Europe | 1 | 2017 | 88 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2018 | 167 | 0.040 |
Why?
|
| Body Fat Distribution | 1 | 2017 | 23 | 0.040 |
Why?
|
| District of Columbia | 1 | 2017 | 68 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 424 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2018 | 228 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2021 | 1349 | 0.040 |
Why?
|
| Heterozygote | 1 | 2016 | 91 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2016 | 8 | 0.040 |
Why?
|
| Atrial Flutter | 1 | 2016 | 7 | 0.040 |
Why?
|
| Survival Rate | 1 | 2017 | 310 | 0.040 |
Why?
|
| Exercise Therapy | 1 | 2016 | 64 | 0.040 |
Why?
|
| Residual Volume | 1 | 2015 | 2 | 0.030 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 2015 | 5 | 0.030 |
Why?
|
| Registries | 1 | 2018 | 330 | 0.030 |
Why?
|
| Total Lung Capacity | 1 | 2015 | 4 | 0.030 |
Why?
|
| Length of Stay | 1 | 2017 | 184 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2015 | 49 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 161 | 0.030 |
Why?
|
| Brain | 1 | 2023 | 1268 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 102 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2021 | 1961 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 16 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2014 | 21 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2018 | 486 | 0.030 |
Why?
|
| Pharmacogenetics | 1 | 2014 | 45 | 0.030 |
Why?
|
| Young Adult | 2 | 2015 | 4012 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2014 | 155 | 0.030 |
Why?
|
| Adolescent | 2 | 2015 | 5035 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2013 | 27 | 0.030 |
Why?
|
| Incidence | 1 | 2016 | 882 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2013 | 8 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2013 | 15 | 0.030 |
Why?
|
| Antigens, CD34 | 1 | 2013 | 18 | 0.030 |
Why?
|
| Massachusetts | 1 | 2013 | 29 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 180 | 0.030 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2013 | 33 | 0.030 |
Why?
|
| Ribosomes | 1 | 2012 | 27 | 0.030 |
Why?
|
| TRPM Cation Channels | 1 | 2013 | 35 | 0.030 |
Why?
|
| Netherlands | 1 | 2012 | 9 | 0.030 |
Why?
|
| Cholesterol, HDL | 1 | 2012 | 87 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2012 | 23 | 0.030 |
Why?
|
| Diet Surveys | 1 | 2012 | 96 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2012 | 118 | 0.030 |
Why?
|
| Serum Albumin | 1 | 2012 | 49 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2013 | 212 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2012 | 91 | 0.030 |
Why?
|
| ROC Curve | 1 | 2012 | 138 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 109 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 123 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2013 | 131 | 0.030 |
Why?
|
| Life Style | 1 | 2013 | 288 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 184 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2013 | 287 | 0.020 |
Why?
|
| Body Size | 1 | 2010 | 28 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 233 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 964 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2013 | 306 | 0.020 |
Why?
|
| Glucose | 1 | 2011 | 217 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 522 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 727 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 592 | 0.020 |
Why?
|
| Mice | 1 | 2012 | 5668 | 0.010 |
Why?
|
| Animals | 1 | 2012 | 14307 | 0.010 |
Why?
|